ATG5型
肾
自噬
纤维化
线粒体分裂
马兜铃酸
癌症研究
糖酵解
炎症
肾脏疾病
医学
生物
内科学
线粒体
细胞生物学
生物化学
细胞凋亡
新陈代谢
遗传学
作者
Yan Hu,Jinqing Li,Hui Chen,Yingfeng Shi,Xiaoyan Ma,Yì Wáng,Xialin Li,Qin Zhong,Yishu Wang,Daofang Jiang,Shougang Zhuang,Na Liu
标识
DOI:10.1002/advs.202414673
摘要
Although significant progress in identifying molecular mediators of fibrosis is made, there is still controversy regarding the role and mechanism of autophagy in kidney fibrosis. Here, this study finds that autophagy related 5 (ATG5) is obviously increased in uric acid (UA), aristolochic acid (AA) and transforming growth factor-β1 (TGF-β1)-induced HK-2 cells, as well as in kidneys from patients with chronic kidney disease (CKD) and mice with hyperuricemic nephropathy (HN), aristolochic acid nephropathy (AAN) and unilateral renal ischemia-reperfusion injury (uIRI). Conditional deletion of ATG5 in HN, AAN and uIRI murine models significantly alleviated aberrant glycolysis, attenuated pathological lesions, and improved kidney function. Mechanistically, ATG5 mediates the binding between heat shock protein 90 (HSP90) and hypoxia-inducible factor 1alpha (HIF-1α), thereby enhancing the stability of HIF-1α and further promoting the overactivation of glycolysis. Subsequently, the aberrant glycolysis facilitated the occurrence of mitochondrial fission and inflammatory response, thus leading to kidney fibrosis. Taken together, the study provides solid evidence supporting that persistent activation of ATG5 in kidney tubules promotes kidney fibrosis. The profibrotic function of ATG5 is related to the regulation on HSP90-HIF-1α-mediated glycolysis, resulting in mitochondrial fission and renal inflammation. Thus, ATG5 may be a novel therapeutic target for kidney fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI